• 中国科技论文统计源期刊（中国科技核心期刊）
  • 中国医药卫生核心期刊
  • 中国抗癌协会系列期刊
中国胸部肿瘤研究协作组（CTONG）
Advanced Search

Co-Amplification, Double Targeting, More Efficacious
KANG Jin, YANG Jin-ji
2017, 17(3): 129-129. DOI: 10.12019/j.issn.1671-5144.2017.03.001
Abstract PDF
The Acquired MET Y1248H and D1246N Mutations Mediate Resistance to MET Inhibitors Cancer Appear Again
LI An-na
2017, 17(3): 130-131. DOI: 10.12019/j.issn.1671-5144.2017.03.002
Abstract PDF
Small but Unnegligible Groups in The Era of Precision Medicine
KANG Jin, YANG Jin-ji
2017, 17(3): 132-132. DOI: 10.12019/j.issn.1671-5144.2017.03.003
Abstract PDF
Targeting New Star: NTRK1 Fusion
WANG Wen-xian, XU Chun-wei, CHEN Gang
2017, 17(3): 133-133. DOI: 10.12019/j.issn.1671-5144.2017.03.004
Abstract PDF
Explore, Progress, Confused: Triple Negative Breast Cancer Therapy in 2017
LIAO Ning
2017, 17(3): 134-139. DOI: 10.12019/j.issn.1671-5144.2017.03.005
Abstract PDF
The Interpretation of CALGB 40603 Trial: The Addition of Carboplatin and/or Bevacizumab to Neoadjuvant Chemotherapy Improve Pathologic Complete Response Rates in StageⅡto Ⅲ Triple Negative Breast Cancer
Reviewers： YAO He-rui, You Kai-yun, WANG Ying, Literature Co-workers： YU Yun-fang
2017, 17(3): 140-145. DOI: 10.12019/j.issn.1671-5144.2017.03.006
Abstract PDF
The Safety and Therapeutic Effect Evaluation of Pembrolizumab in Patients with Advanced PD-L1 Positive Triple Negative Breast Cancer
WANG Xian-ming, TANG Jing
2017, 17(3): 146-149. DOI: 10.12019/j.issn.1671-5144.2017.03.007
Abstract PDF
Neoadjuvant Carboplatin in Patients with Triple Negative Early Breast Cancer Can Improve The Pathological Complete Response Rate
PANG Dan-mei, WEN Ling-zhu
2017, 17(3): 150-152. DOI: 10.12019/j.issn.1671-5144.2017.03.008
Abstract PDF
I-SPY2 Provides The New Trend of Breast Cancer Clinical Trials
XU Rui-lian, REN Chong-yang
2017, 17(3): 153-154. DOI: 10.12019/j.issn.1671-5144.2017.03.009
Abstract PDF
Clinical Research of Severe Drug Eruption with Combined Different Dose Intravenous Immunoglobulin and Glucocorticoid
WANG Hong-yan, WANG Qun
2017, 17(3): 155-158. DOI: 10.12019/j.issn.1671-5144.2017.03.010
Abstract PDF
The Clinical Analysis of Protecting Side Branch with A Small Balloon in Treating Coronary Bifurcation Lesion
GONG Hui, HUANG Ding, ZHANG Xiang-yang
2017, 17(3): 159-162. DOI: 10.12019/j.issn.1671-5144.2017.03.011
Abstract PDF
Effects of Glucagon-Like Peptide-1 Analog on CDAA Diet-Induced Models of Nonalcoholic Fatty Liver Fibrosis in Rats
CHEN Xin-qun, XU Li-shu, LI Dong-feng, DENG Wei-ping
2017, 17(3): 163-170. DOI: 10.12019/j.issn.1671-5144.2017.03.012
Abstract PDF
Function of The Regional Blockade with Ropivacaine on The Enhanced Recovery after Surgery of Pediatric Patients with Hernias
YANG Hui-ju, YU Dong-nan, MA Jue, HU Shi-xiong, ZHANG Deng-wen, WANG Sheng
2017, 17(3): 171-174. DOI: 10.12019/j.issn.1671-5144.2017.03.013
Abstract PDF
Hypothesis Test Based on Re-Sampling for Meta-Analysis of Gene Expression Profiling Studies Application
HE Jie-yu, SUN Jin-fang, WANG Li-na, MIN Jie, YU Xiao-jin
2017, 17(3): 175-179. DOI: 10.12019/j.issn.1671-5144.2017.03.014
Abstract PDF
Tolerance and Urinary Bladder Toxicity Study of Phenethyl Isothiocyanate Capsules at Multiple Doses in Human Body
HE Guo-dong, MAI Li-ping, GU Liang, CHEN Ju-ying, CHENG Zhi-wei, GUO Lan, YANG Min
2017, 17(3): 180-183. DOI: 10.12019/j.issn.1671-5144.2017.03.015
Abstract PDF
A Literature Review of Radiogenomics Predicting Tumor Responses to Neoadjuvant Chemotherapy in Breast Cancer
XIONG Qian-qian, WANG Kun
2017, 17(3): 184-189. DOI: 10.12019/j.issn.1671-5144.2017.03.016
Abstract PDF
Diagnosis and Treatment of Juvenile Myelomonocytic Leukemia
ZHANG Jin-fang, LIN Yu-deng
2017, 17(3): 190-192. DOI: 10.12019/j.issn.1671-5144.2017.03.017
Abstract PDF

Copyright © 2024 Journal of Evidence-Based Medicine粤ICP备15000268号

Address：Editorial Office of Evidence-based Medicine, Guangdong Provincial People's Hospital, No.123, Huifuxi Road, Guangzhou 510180, China，Tel：020-83844620，E-mail：xzyxzz@163.net